Angiolin positively affects the state of myocardial nitroxidergic system in experimental ischemia—it increases NO synthesis by increasing eNOS expression, increases NO bioavailability, and reduces parasitic reactions by decreasing iNOS hyperactivity. The gene discussed is NOS3; the disease is ischemia.